Lemaitre Vascular (LMAT) EBT (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of EBT data on file, last reported at $19.7 million in Q1 2026.

• On a quarterly basis, EBT rose 38.14% year-over-year to $19.7 million in Q1 2026; TTM through Mar 2026 was $80.6 million, a 38.23% increase from a year earlier, with the FY2025 full-year figure at $75.2 million, up 32.19% from the prior year.
• EBT for Q1 2026 stood at $19.7 million, down from $20.3 million in the prior quarter.
• Over the last five years, EBT for LMAT reached as high as $22.6 million in Q3 2025 and fell as low as $5.5 million in Q2 2022.
• Historically, EBT has averaged $12.8 million across 5 years, with a median of $12.8 million in 2024.
• Across the five-year window, EBT plunged 46.93% in 2022 and jumped 85.99% in 2023, its largest moves.
• Year by year, EBT stood at $6.6 million in 2022, then soared by 71.88% to $11.3 million in 2023, then grew by 23.94% to $14.0 million in 2024, then jumped by 44.78% to $20.3 million in 2025, then fell by 3.09% to $19.7 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $19.7 million in Q1 2026, $20.3 million in Q4 2025, and $22.6 million in Q3 2025.